Jeffrey A. Fielkow Purchases 2,500 Shares of TriMas Co. (NASDAQ:TRS) Stock

TriMas Co. (NASDAQ:TRS) Director Jeffrey A. Fielkow bought 2,500 shares of the firm’s stock in a transaction dated Friday, February 28th. The stock was purchased at an average price of $20.78 per share, with a total value of $51,950.00. Following the completion of the purchase, the director now directly owns 11,013 shares of the company’s stock, valued at approximately $228,850.14. This trade represents a 29.37 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

TriMas Price Performance

Shares of TRS stock opened at $21.89 on Wednesday. TriMas Co. has a twelve month low of $19.33 and a twelve month high of $28.51. The company has a current ratio of 2.83, a quick ratio of 1.44 and a debt-to-equity ratio of 0.60. The company has a market capitalization of $888.12 million, a PE ratio of 34.20 and a beta of 0.66. The firm has a fifty day simple moving average of $23.66 and a 200-day simple moving average of $25.08.

TriMas Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 7th. Shareholders of record on Friday, February 28th will be paid a dividend of $0.04 per share. The ex-dividend date of this dividend is Friday, February 28th. This represents a $0.16 dividend on an annualized basis and a yield of 0.73%. TriMas’s dividend payout ratio (DPR) is 27.12%.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in TRS. Bank of America Corp DE boosted its stake in TriMas by 127.3% during the 4th quarter. Bank of America Corp DE now owns 3,513,638 shares of the industrial products company’s stock valued at $86,400,000 after acquiring an additional 1,967,738 shares during the last quarter. Bellecapital International Ltd. bought a new position in TriMas during the 4th quarter valued at $29,160,000. Impax Asset Management Group plc boosted its stake in TriMas by 216.4% during the 3rd quarter. Impax Asset Management Group plc now owns 410,000 shares of the industrial products company’s stock valued at $10,467,000 after acquiring an additional 280,431 shares during the last quarter. Raymond James Financial Inc. bought a new position in TriMas during the 4th quarter valued at $6,698,000. Finally, Wellington Management Group LLP boosted its stake in TriMas by 10.7% during the 3rd quarter. Wellington Management Group LLP now owns 2,619,359 shares of the industrial products company’s stock valued at $66,872,000 after acquiring an additional 252,537 shares during the last quarter. 99.42% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on the stock. BWS Financial restated a “buy” rating and issued a $40.00 target price on shares of TriMas in a research note on Friday, February 28th. StockNews.com upgraded shares of TriMas from a “sell” rating to a “hold” rating in a research note on Wednesday, November 13th.

About TriMas

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.